JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Gossamer Bio Inc

Cerrado

SectorSalud

1.84 2.79

Resumen

Variación precio

24h

Actual

Mínimo

1.84

Máximo

1.91

Métricas clave

By Trading Economics

Ingresos

-3.6M

-37M

Ventas

510K

9.9M

Margen de beneficio

-370.492

Empleados

144

EBITDA

-1.9M

-34M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+400% upside

Dividendos

By Dow Jones

Próximas Ganancias

8 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

148M

398M

Apertura anterior

-0.95

Cierre anterior

1.84

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

361 / 375 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Gossamer Bio Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

25 jul 2025, 17:53 UTC

Principales Movimientos del Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750 Million Windfall

25 jul 2025, 15:58 UTC

Ganancias
Principales Movimientos del Mercado

Aon Shares Rise After 2Q Earnings Beat

25 jul 2025, 15:08 UTC

Principales Movimientos del Mercado

AST SpaceMobile Shares Slide After Convertible Notes, Stock Offerings

25 jul 2025, 21:40 UTC

Charlas de Mercado

Starbucks' Spending Hikes Are Misdirected -- Market Talk

25 jul 2025, 21:23 UTC

Charlas de Mercado

Honeywell's Growth Seen Holding Up Despite Recent Headwinds -- Market Talk

25 jul 2025, 20:40 UTC

Ganancias

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 jul 2025, 20:10 UTC

Ganancias

These Stocks Moved the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 jul 2025, 19:56 UTC

Ganancias

Correction to Why Bargain Hunters Are Flocking to 'Bin Stores' -- Barrons.com on July 20

25 jul 2025, 19:14 UTC

Charlas de Mercado

Oil Futures Post Back-to-Back Weekly Losses -- Market Talk

25 jul 2025, 19:10 UTC

Charlas de Mercado

U.S. Natural Gas Futures Appear to Stabilize -- Market Talk

25 jul 2025, 19:01 UTC

Ganancias

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 jul 2025, 18:45 UTC

Charlas de Mercado

Gold Ends Down Week on Lower Note -- Market Talk

25 jul 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

Sale Could Fetch Around $1B, Sources Say -- WSJ

25 jul 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

LVMH in Talks to Sell Marc Jacobs -- WSJ

25 jul 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

Suitors for Marc Jacobs Include Authentic, Bluestar Alliance and WHP Global, Sources Say -- WSJ

25 jul 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

LVMH Exploring Sale of Fashion Brand Marc Jacobs, Sources Say -- WSJ

25 jul 2025, 17:38 UTC

Principales Movimientos del Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750M Windfall

25 jul 2025, 17:26 UTC

Charlas de Mercado

U.S. Oil Rig Count Extends Decline -- Market Talk

25 jul 2025, 17:13 UTC

Ganancias

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 jul 2025, 16:46 UTC

Ganancias

Volkswagen Teases Made-in-America Audis, Porsches After $1.5 Billion Tariff Hit -- 2nd Update

25 jul 2025, 16:45 UTC

Ganancias

Apple Earnings Are Next Week. Why This Analyst Says Be Cautious. -- Barrons.com

25 jul 2025, 16:27 UTC

Ganancias

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

25 jul 2025, 16:02 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Is Losing Its Buffett Premium. Now Is the Time to Buy. -- Barrons.com

25 jul 2025, 15:34 UTC

Ganancias

Intel's Harsh Reality Nullifies Tariff Boost -- WSJ

25 jul 2025, 15:06 UTC

Charlas de Mercado

Base Metal Prices Fall on Stronger U.S. Dollar -- Market Talk

25 jul 2025, 15:05 UTC

Ganancias

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Comfort Systems, and More -- Barrons.com

25 jul 2025, 14:45 UTC

Charlas de Mercado

Oil Rangebound Amid U.S.-EU Trade Uncertainty -- Market Talk

25 jul 2025, 14:44 UTC

Charlas de Mercado

Gold Futures Set to End Week Lower on Easing Trade War Concerns -- Market Talk

25 jul 2025, 14:36 UTC

Charlas de Mercado
Ganancias

Phillips 66 CEO Says California Administration Supports of LA Plant Closure -- Market Talk

Comparación entre iguales

Cambio de precio

Gossamer Bio Inc Esperado

Precio Objetivo

By TipRanks

400% repunte

Estimación a 12 meses

Media 9.2 USD  400%

Máximo 15 USD

Mínimo 4 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Gossamer Bio Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

6

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.06 / 1.23Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

361 / 375 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.